Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.

Achhra, A C; Phillips, A; Emery, S; MacArthur, R D; Furrer, H; De Wit, S; Losso, M; Law, M G

Achhra, A C; Phillips, A; Emery, S; MacArthur, R D; Furrer, H; De Wit, S; Losso, M; Law, M G.

Affiliation

Achhra AC; Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
Phillips A; Research Department of Infection & Population Health, University College London, London, UK.
Emery S; Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
MacArthur RD; Wayne State University, Detroit, MI, USA.
Furrer H; Infectious Diseases, University Hospital, Bern, Switzerland.
De Wit S; Department of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium.
Losso M; J.M. Ramos Mejía Hospital, Buenos Aires, Argentina.
Law MG; Kirby Institute, UNSW Australia, Sydney, NSW, Australia.

HIV Med ; 16(7): 449-54, 2015 Aug.

Article in En | MEDLINE | ID: mdl-25959989

Subject(s)

Anti-HIV Agents/administration & dosage; HIV Infections/immunology; Inflammation/blood; Adult; Biomarkers/blood; Blood Coagulation/immunology; C-Reactive Protein/immunology; CD4 Lymphocyte Count; Disease Progression; Female; Fibrin Fibrinogen Degradation Products/immunology; HIV Infections/blood; HIV Infections/drug therapy; Humans; Interleukin-6/immunology; Male; Predictive Value of Tests; Retrospective Studies; Risk Factors

Key words

C-reactive protein; CD4 count; D-dimer; HIV; antiretroviral therapy; coagulation; highly active antiretroviral therapy; immunological response; inflammation; interleukin-6

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Inflammation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google